Hospital
ST. Vincent Randolph Hospital, INC.
ST. Vincent Randolph Hospital, INC. was paid $4.06M by Medicaid between Jan 2018 and Nov 2024, across 66 billing codes. Its largest line is 99283, emergency room visit (moderate) — 44% of everything it billed.
33Billing provider infoST. VINCENT RANDOLPH HOSPITAL, INC.
WINCHESTER, IN 47394
WINCHESTER, IN 47394
33aNPI1609826783assigned 05/11/2006
33bProvider typeCritical Access Hospital
28Total paid$4.06M
24GClaims85,776
24DCodes billed66
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Indiana
Rank by total paid#16 of 26
Median peer was paid$4.16M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,715 | $124K | |
| 2019 | 6,276 | $134K | |
| 2020 | 9,268 | $399K | |
| 2021 | 13,220 | $710K | |
| 2022 | 18,314 | $1.06M | |
| 2023 | 15,536 | $899K | |
| 2024incomplete | 11,447 | $733K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 44% | 10,948 | 9,800 | $1.81M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 20% | 7,353 | 6,005 | $803K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.1% | 2,413 | 2,023 | $209K |
| 71046 | Radiologic examination, chest; 2 views | 4.8% | 1,604 | 1,391 | $194K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.8% | 1,236 | 909 | $153K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.6% | 3,734 | 3,324 | $147K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.6% | 2,084 | 1,811 | $145K |
| 80053 | Comprehensive metabolic panel | 2.7% | 15,993 | 13,345 | $108K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.4% | 1,860 | 1,451 | $100K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.7% | 14,460 | 12,052 | $69K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.5% | 2,256 | 1,762 | $61K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.2% | 321 | 301 | $48K |
54 more codes
| 71045 | Radiologic examination, chest; single view | <1% | 240 | $26K |
| 87634 | <1% | 419 | $23K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 76 | $14K |
| 80061 | Lipid panel | <1% | 1,461 | $11K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 183 | $11K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 742 | $10K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 792 | $10K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 56 | $10K |
| 83690 | <1% | 1,898 | $9K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,740 | $8K |
| 85027 | <1% | 1,092 | $7K | |
| 81001 | <1% | 3,226 | $7K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,341 | $7K |
| 84484 | <1% | 988 | $6K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 631 | $6K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 47 | $6K |
| 80306 | <1% | 775 | $6K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 59 | $5K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 167 | $5K |
| 83880 | <1% | 352 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 357 | $4K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 347 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 963 | $3K |
| 74018 | <1% | 14 | $3K | |
| 82728 | <1% | 237 | $2K | |
| 83735 | <1% | 467 | $2K | |
| 87088 | <1% | 504 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 50 | $1K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 50 | $979.80 |
| 83605 | <1% | 118 | $945.82 | |
| 84702 | <1% | 100 | $819.72 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 36 | $765.29 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 39 | $730.63 |
| 86803 | <1% | 55 | $554.69 | |
| 81025 | <1% | 98 | $540.48 | |
| 87510 | <1% | 43 | $516.35 | |
| 87480 | <1% | 43 | $511.57 | |
| 87660 | <1% | 43 | $505.95 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 21 | $448.56 |
| 86140 | <1% | 166 | $422.44 | |
| 87481 | <1% | 21 | $319.59 | |
| 84144 | <1% | 19 | $292.04 | |
| 85730 | <1% | 103 | $97.86 | |
| 87430 | <1% | 42 | $79.15 | |
| 83550 | <1% | 17 | $75.16 | |
| 85379 | <1% | 21 | $68.22 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 15 | $67.44 |
| 85610 | <1% | 104 | $66.73 | |
| 81003 | <1% | 40 | $56.25 | |
| 83540 | <1% | 17 | $55.64 | |
| 82950 | <1% | 14 | $50.75 | |
| 87081 | <1% | 24 | $16.68 | |
| A9270 | Non-covered item or service | 0% | 29 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialYOUNG, KATHY (INTERIM ADMINISTRATOR)
| Provider | Location | Paid |
|---|---|---|
| ST. Joseph Hospital & Health Center, INC. | Kokomo, IN | $17.89M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.